University of Louisville's Price Institute of Surgical Research Banner Decorative horizontal bar


Digestive Surgery
Pediatric Surgery
Reconstructive Surgery
Surgical Infection
Surgical Oncology
Thoracic & Cardiovascular Surgery
Trauma Research


Division of Thoracic & Cardiovascular Surgery

Dr. Sufan Chien In Focus: Tissue Ischemia and Energy Metabolism
Sufan Chien, MD
Division of Thoracic & Cardiovascular Surgery

A Novel Way to Deliver ATP to Normal and Ischemic Cells
Tissue ischemia due to reduced blood flow or disturbed oxygen supply is a universal event in various forms of trauma and diseases. The cessation of blood flow not only halts the influx of oxygen and nutrients, but also stops the carrying away of toxic wastes. While many of these changes are poorly understood, several important inter-related events are involved, including:

  • The decline of high-energy phosphates
  • Accumulation of metabolic intermediates
  • Cell swelling
  • Intracellular acidosis
  • Accumulation of oxygen free radicals
  • Structural changes.

Damage Control
Among these changes, depletion of high-energy phosphates is the fundamental cause of ischemic tissue damage. Direct infusion of high-energy phosphates such as adenosine triphosphate (ATP) would be a simple solution to block this effect, and administration of ATP has been reported to improve tissue protection during ischemia in many models and species, including heart, kidney, liver, and various forms of shock.

Restoring Energy
Molecules like ATP normally cannot pass the cell membrane in quantities large enough to satisfy tissue metabolic requirements. Further, the half-life of free ATP in the blood is less than 40 seconds—limiting its efficacy as a bioenergetic substrate. For this reason, ATP therapy has yet to translate into a clinically useful technique.

Promising Research
We have developed a new ATP-encapsulation technique to deliver high-energy phosphate directly into the cytosol of normal or ischemic cells. Preliminary research indicates that it may be a valuable tool in treating diabetic wounds such as chronic foot ulcers. We have received two NIH Grants to continue our research, a R01 and a R44/SBIR. If the research proves to be successful, it may pave the way to totally new therapeutic approach to various clinical ischemic conditions, such as shock, stroke, heart attack, coronary artery disease, spinal cord injury, cardiopulmonary bypass surgery, organ transplantation, severe trauma, and whole-body poisoning.

Return to Top of the Page

Decorative horizontal bar

Laboratories | Research Opportunities | Grants & Publications | About Us | Contacts | Privacy | Site Map | Home

Copyright © 2012 by the Department of Surgery, University of Louisville. All rights to materials contained within this Web site are reserved.
Webmaster: Information Specialists LLC